epharma logo

E-PHARMA is an Italian Contract Development and Manufacturing Organization (CDMO), highly specialized in SOLID ORAL DELIVERY FORMS

Comprehensive single-source provider from drug product development through commercial manufacture.

High level of outsourcing from dossier technical evaluation to private label manufacturing.

We independently develop new pharmaceutical products on the basis of our technology platforms, delivery forms and know-how.

We out-license our registration dossiers, fully developed in house, for the partners to register and apply for a Marketing Authorisation in their country/-ies with their own trademark.

Technologies

Effervescent formulations are solid immediate release forms that need to be dissolved in water at the time of administration.

Sublingual technology refers to the pharmacological route of administration by which drugs diffuse into the blood through tissues under the tongue.

Designed to disintegrate rapidly on contact with saliva and enable oral administration without water or chewing.

Soluble formulations are solide immediate release forms that need to be dissolved in water with rapid stirring at the time of administration.

Pharmaceutical Forms

  • EFFERVESCENT TABLETS
  • GRANULES FOR SUSPENSION
  • EFFERVESCENT GRANULES
  • SOLUBLE GRANULES
  • ORALLY DISINTEGRATING GRANULES
  • CHEWABLE TABLETS
  • ORALLY DISINTEGRATING TABLETS
  • SUBLINGUAL TABLETS
  • SUBLINGUAL GRANULES

Certifications

EU GMP

Certificate issued by the Italian Medicines Agency (AIFA)

Italian Health Authorities

Authorized by the Italian Health Authorities to produce pharmaceuticals and food supplements

Italian Health Authorities

Authorized by the Italian Health Authorities to use narcotic drugs or psychotropic substances and licence for drug precursors

FSI «SID&GP»

Authorized by the Ministry of Industry and Trade of the Russian Federation on GMP compliance

FDA registered

FDA registered for the US market of food supplements and for medical devices

TGA

TGA registered for the Australian market of food supplements

UNITED ARAB EMIRATES

United Arab Emirates registered for the market of food supplements

OHSAS 18001

OHSAS 18001 System certification on Health & Safety at workplace

FSSC 22000

FSSC 22000 Food Safety System Certification 

HALAL

HALAL Certificate on production lines

KOSHER

KOSHER Certificate (product based)

Patents

Granulate for the formulation of orodispersible tablets

European Patent EP 2238974, exp. 2029 US
Patent granted US9861581, exp. 2030

New strengthened blister pack

European Patent EP 2353573, exp. 2030
US Patent granted US9850051, exp. 2035
Canada Patent granted CA2730464, exp. 2031

 

Awards Winner 1

Anti-abuse pharmaceutical composition

Patent (Italy)102016000122469, exp. 2036
European Patent EP329939, exp. 2037 US
Patent granted US2018/0154002, published

New Products

for Menopause Syndrome

for Eye Health

for Memory Enhancing

for Cognitive functions

for Metabolic Syndrome

for PCOS Syndrome

Immune System Boosters

14 - 16 May 2024 - Geneva, Switzerland

 

3 - 4 June, Dublin, Ireland

 

11 - 12 September 2024Paris, France

 

8 - 10 October 2024 Milan, Italy